Chronic Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation Using Antiarrhythmic Drugs: Update 2010.
Atrial fibrillation (AF) is a growing public health concern. For most patients the treatment of AF involves antiarrhythmic drugs. Despite the widespread use of antiarrhythmic drugs for the conversion of AF and maintenance of normal sinus rhythm, their use is limited by modest efficacy, frequent intolerance, and the potential for serious ventricular proarrhythmia and organ toxicity. Better medications are urgently needed. Optimizing the way current agents are used is vital in the interim. This article discusses such issues.